Detailed contribution information

Back to list

Contribution title Bimekizumab response through 3 years in patients with plaque psoriasis who stopped and re-started treatment
Authors
  1. Antonio Costanzo Costello Medical Consulting Limited
  2. Kim Papp Probity Medical Research and Alliance Clinical Trials
  3. Christopher E. M. Griffiths University of Manchester
  4. David Rosmarin Indiana University School of Medicine
  5. Luis Puig Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona
  6. George Han Mount Sinai Medical Center
  7. Nicola Tilt UCB Pharma
  8. Krista Wixted UCB Pharma
  9. Balint Szilagyi UCB Pharma
  10. Jérémy Lambert UCB Pharma
  11. Nicolas Hurni UCB-Pharma SA Presenter
  12. Andrew Blauvelt Oregon Medical Research Center
Form of presentation Poster
Topic
  • 1.1 Inflammatory and immune-mediated dermatoses